Blueprint Medicines Corporation - Common Stock (BPMC)
$91.26
1.22 (1.32%)
BPMC Stock Quote Delayed 30 Minutes
BPMC Stock Earnings: Blueprint Medicines Beats EPS, Beats Revenue for Q1 2024
BPMC stock results show that Blueprint Medicines beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
5.80B
PE Ratio
-83.72
EPS
-1.09
Volume (Avg. Vol.)
685,402
Day's Range
$90.88 - $93.25
52-Week Range
$80.68 - $121.90
Dividend & Yield
N/A (N/A)
